LATEST ANNOUNCEMENT

Anatara’s IBS-D clinical trial to leverage Microba Life Sciences’ precision microbiome analysis

Precision microbiome science company, Microba Life Sciences, will work with Anatara Life Sciences (ASX:ANR) to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D.